← FDA Drug Approvals (Drugs@FDA)

ILEVRO

NDA · New Drug Application · Sponsor: HARROW EYE · Approved 2012-10-16

Drug application

FDA Application #

NDA203491

Application type

New Drug Application

Brand name

ILEVRO

Generic name

NEPAFENAC

Active ingredients

NEPAFENAC

Dosage form

SUSPENSION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

HARROW EYE

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2012-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown